Clinical trial
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
NCT06167642
Study timeline
Study start (actual)2023-05-22Date precision: day
Registry last updated2026-06-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Tomography, Optical Coherenceunresolved
Retinal Degenerationunresolved
Visual Acuityunresolved
Interventions
OfatumumabDRUG · verified · RxNorm: ofatumumab
Sponsors & collaborators
Johns Hopkins Universitylead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06167642 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.